Medlive Technology Co (HKSE:02192) Research & Development: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02192 Medlive Technology Co Ltd HKSE:02192
90 GF Score
Price HK$7.87
GF Value HK$14.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co Research & Development?

Medlive Technology Co HKSE:02192 +0.90% 90 Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medlive Technology Co's Research & Development for the six months ended in Dec. 2025 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Medlive Technology Co  (HKSE:02192) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medlive Technology Co Research & Development Related Terms

Medlive Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Medlive Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medlive Technology Co Research & Development Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02192
90GF Score
Medlive Technology Co Ltd HKSE:02192
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medlive Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
Medlive Technology Co (HKSE:02192) has a Research & Development of HK$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Medlive Technology Co and its competitors.
Is Medlive Technology Co's Research & Development too high?
Medlive Technology Co's current Research & Development is HK$0.0 Mil. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Research & Development compare to VEEV and BTSG?
Medlive Technology Co's Research & Development of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medlive Technology Co and its competitors. Medlive Technology Co's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.87 — trading 47.4% below its estimated fair value. The current Research & Development is HK$0.0 Mil. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of HK$7.87 is trading 47.4% below its estimated GF Value™ of HK$14.95. GuruFocus considers Medlive Technology Co to be Significantly Undervalued.

Key valuation signals for HKSE:02192:

  • Research & Development: HK$0.0 Mil
  • GF Value™: HK$14.95 vs. price of HK$7.87 (47.4% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medlive Technology Co Business Description

Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for HKSE:02192

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.87
Price
HK$14.95
GF Value